Navigation Links
RxElite Registration Statement Suspended
Date:1/4/2008

MERIDIAN, Idaho, Jan. 4 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC Bulletin Board: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, announced today the suspension of their registration statement covering the resale of 53,747,555 shares. The suspension is permitted by the Securities and Exchange Commission in certain cases. The company requested this suspension to protect investors due to material non-public information relating to an acquisition. The Company will release information regarding the acquisition as soon as practical. The suspension of this registration statement is allowable for up to 90 days.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contacts:

Corporate Information

Ph: (208) 288-5550

Toll Free: (800) 414-1901

Fax: (208) 288-1191

Investor Relations

Charlie Forshee, 215-885-4981

investorrelations@rxelite.com

Segue Ventures LLC


'/>"/>
SOURCE RxElite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. RxElite Files Registration Statement with Securities and Exchange Commission
2. RxElite Announces 3rd Quarter Financials Conference Call
3. RxElite Registration Statement Declared Effective by Securities and Exchange Commission
4. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
5. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
6. Gentiva(R) Health Services Files Universal Shelf Registration Statement
7. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. Pearson Introduces Smart Technology for Collecting Patient Registration Information
10. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
11. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... firm, announced today that nominations will be accepted May 23, 2016 through ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... In Pursuit ... of noteworthy California winemakers will close operations at the end of 2016. , ... in California wine,” Hirsch said. “As we look back on what we have achieved, ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... care to residents of Westchester County for over 24 years, recently hosted its ... community members joined HOW for two remembrance ceremonies, each concluding with the release ...
(Date:5/23/2016)... ... May 23, 2016 , ... Octo Consulting Group, a leading provider of innovative ... to announce they have recently won two awards from AFCEA International. Octo was ... the Year. Additionally, Octo VP of Civilian Affairs, Naina Leo, was named a winner ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Overweight and ... friendships and hard on the budget, but most of all, it can be hard ... artificial sweetener use, packaged diet food—isn’t making a dint in childhood obesity statistics or ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... PUNE, India , May 20, 2016 /PRNewswire/ ... Professional Survey Report 2016 to Medical Devices of ... professional and in-depth survey on the current state ... basic overview of the industry like definitions, classifications, ... gives information about manufacturing process like Raw Material ...
(Date:5/20/2016)... India , May 20, 2016 ... - Pipeline Review, H1 2016" market research report ... Plaque Psoriasis (Psoriasis Vulgaris), complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ...
(Date:5/19/2016)... 19, 2016 According to a new market ... Countries, (U.S., Germany , France ... , and Japan )", published by MarketsandMarkets, The ... a CAGR of 13.9% from 2016 to 2021.      ... market data Tables spread through 26 Pages and in-depth TOC on ...
Breaking Medicine Technology: